Madrigal Pharmaceuticals, Inc.
MDGL
Revenue
212.80M
▲75.55M▲55.05%
3 Months ChangeAssets
1.02B
▲18.75M▲1.88%
3 Months ChangeLiabilities
319.40M
▲33.41M▲11.68%
3 Months ChangeFree Cash Flow
-88.89M
▲60.62M▲40.55%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 10-Q
ID: 0001628280-24-044445
2024-10-31
Form 8-K
ID: 0001193125-24-248137
2024-08-07
Form 10-Q
ID: 0001628280-24-035400
2024-08-07
Form 8-K
ID: 0001193125-24-195400
2024-06-27
Form 8-K
ID: 0001193125-24-170634
2024-05-07
Form 8-K
ID: 0001193125-24-133196
2024-05-07
Form 10-Q
ID: 0001628280-24-020865
2024-05-07
Form 8-K
ID: 0001193125-24-132559
2024-04-02
Form 8-K
ID: 0001193125-24-084797
2024-03-20
Form 8-K
ID: 0001193125-24-072706